Ohio 136th General Assembly Status: Introduced Bipartisan · 1 D · 1 R cosponsors

HB 263 — Cap cost sharing for prescription insulin drugs, diabetes devices

Last action — Referred to committee

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the House. Introduced May 13, 2025. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Stalled 26% · moderate confidence

  • Introduced

    Current position in the legislative process.

  • 2 sponsors

    1 primary, 1 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (1 D · 1 R) — cross-party backing.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

To enact section 3902.65 of the Revised Code to cap cost sharing for prescription insulin drugs, diabetes devices, and diabetic ketoacidosis devices.

Bill Text

Action History

  1. As Introduced

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 1 co-sponsors · 132 not signed on

Sponsors (1)

Co-sponsors (1)

Not signed on (132)

132 members have not signed on to this bill.

Show all 132 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 263 do?
To enact section 3902.65 of the Revised Code to cap cost sharing for prescription insulin drugs, diabetes devices, and diabetic ketoacidosis devices.
Who sponsors HB 263?
HB 263 is sponsored by Munira Abdullahi (Democratic) and Thomas Hall (Republican).
What is the current status of HB 263?
This bill has been introduced in the House. Introduced May 13, 2025. It must pass committee before a floor vote.
Where can I track HB 263?
Track HB 263 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 263

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 263

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →